This document aims to support the Regional Medicines Optimisation Committees (RMOC) position statement; “Oral vitamin B supplementation in alcoholism” by identifying CCGs and geographical areas where prescribing within primary care may not be in line with the recommendations.

There is ongoing prescribing of vitamin B complex products despite national and local recommendations that this should be reserved for supplementation in the context of refeeding syndrome. Medicines optimisation teams should be advised to review the formulary status of vitamin B compound products and implement a deprescribing programme if necessary.

This review is older than 18 months; in view of the continued emergence of new evidence, readers are recommended to re-check the biomedical literature.

There are three versions of this publication; please select the appropriate version for your region below.